LRMR 8-K: Fda approval
Larimar Therapeutics
Filed with the SEC on · accession 0001193125-26-453586
LRMR filed a 8-K (current report) with the SEC on Nov 9, 2026. Larimar Therapeutics announced it completed its rolling Biologics License Application (BLA) submission to the FDA seeking accelerated approval of nomlabofusp for the treatment of Friedreich's ataxia. The stock moved +5.9% by the first close after the filing.
Summary of the filing
Larimar Therapeutics announced it completed its rolling Biologics License Application (BLA) submission to the FDA seeking accelerated approval of nomlabofusp for the treatment of Friedreich's ataxia. The company also disclosed preliminary cash, cash equivalents, and marketable securities of approximately $128.7 million as of September 30, 2026.
Key details
How LRMR stock reacted
Close before
$2.39
Nov 6, 2026
First close after
+5.86%
$2.53
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for LRMR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for LRMR?
Click hereFrequently asked questions
What did LRMR file with the SEC on Nov 9, 2026?
LRMR filed a 8-K (Fda approval). Larimar Therapeutics announced it completed its rolling Biologics License Application (BLA) submission to the FDA seeking accelerated approval of nomlabofusp for the treatment of Friedreich's ataxia. The company also disclosed preliminary cash, cash equivalents, and marketable securities of approximately $128.7 million as of September 30, 2026.
What does a fda approval mean for LRMR stock?
For a small biotech one drug can be most of the company’s value. Approval opens sales; a rejection (complete response letter) can delay it by years.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did LRMR stock react to this filing?
LRMR closed at $2.39 before the filing and $2.53 on Nov 9, 2026 (+5.86%).
Other LRMR SEC filings
Get alerts when LRMR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days